Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism

1981 ◽  
Vol 111 (2-3) ◽  
pp. 169-178 ◽  
Author(s):  
Cornelis Jakobs ◽  
Monika Bojasch ◽  
Eberhard Mönch ◽  
Dietz Rating ◽  
Hartmut Siemes ◽  
...  
PEDIATRICS ◽  
1972 ◽  
Vol 49 (5) ◽  
pp. 726-735 ◽  
Author(s):  
Oddvar Stokke ◽  
Lorentz Eldjarn ◽  
Egil Jellum ◽  
Helene Pande ◽  
Per Erik Waaler

A new inborn error of metabolism, characterized by urinary excretion of substantial amounts of β-hydroxyisovaleric acid and β-methylcrotonylglycine, is described. The disorder is most likely due to a defect in the biotin-dependent enzyme β-methylcrotonyl-CoA carboxylase in the leucine degradation pathway. The patient, a 4½-month-old girl, suffered from neurological symptoms similar to those of Werdnig-Hoffmann's disease. No episodes of acidosis could be detected. In periods the urine had a peculiar odor, like that of cat's urine. Relatively large doses of biotin (0.25 mg/day) did not influence the condition. On a diet containing the minimum requirement of leucine, the daily excretion of β-hydroxyisovaleric acid dropped from 400 mg to about 50 mg and β-methylcrotonylglycine from 100 mg to 50 mg. However, the clinical course was unaltered and the patient died at 9 months of age from bronchopneumonia. Biochemically, as well as clinically, the findings are distinctly different from previously described errors in the leucine metabolism.


The Lancet ◽  
1958 ◽  
Vol 272 (7060) ◽  
pp. 1334-1335 ◽  
Author(s):  
JohnB. Jepson ◽  
AlanJ. Smith ◽  
LeonardB. Strang

2019 ◽  
Vol 56 (1) ◽  
pp. e5-e8 ◽  
Author(s):  
Erin E. Bennett ◽  
Kevin Hummel ◽  
Andrew G. Smith ◽  
Nicola Longo

Sign in / Sign up

Export Citation Format

Share Document